Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CTSV | O60911 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14341636 | 0.95 | ALDH1A1 (0.34) | THRBALDH1A1CTSVCTSLCTSS | |
| SCHEMBL1697098 | 0.93 | ALDH1A1 (0.35) | THRBALDH1A1CTSVCTSLCTSS | |
| SCHEMBL12651228 | 0.85 | CTSV (0.33) | ALDH1A1CTSVCTSLCTSSCTSK | |
| SCHEMBL685109 | 0.85 | ALDH1A1 (0.37) | ALDH1A1CTSVCTSLCTSSCTSK | |
| SCHEMBL305299 | 0.80 | CTSV (0.36) | ALDH1A1CTSVCTSLCTSSCTSK | |
| SCHEMBL12783113 | 0.80 | CTSV (0.37) | CTSVCTSLCTSSCTSK | |
| SCHEMBL14509255 | 0.77 | MAPK1 (0.44) | THRBALDH1A1TSHR | |
| SCHEMBL12783089 | 0.77 | CTSV (0.38) | CTSVCTSLCTSSCTSK | |
| SCHEMBL1697108 | 0.76 | CTSV (0.35) | ALDH1A1CTSVCTSLCTSSCTSK | |
| SCHEMBL9883029 | 0.75 | THRB (0.46) | THRBALDH1A1CA1CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100316954-A1 | MONOMER HAVING LACTONE SKELETON, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
| US-20100316954-A1 | MONOMER HAVING LACTONE SKELETON, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
| US-20100316954-A1 | MONOMER HAVING LACTONE SKELETON, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316954-A1 | MONOMER HAVING LACTONE SKELETON, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | RRS1, CNKSR1, LSS | THRB 3911/4885ALDH1A1 1413/4885CTSV 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.